Breaking the Fall Off the Patent Cliff: Can Developing Countries Help Big Pharma?
Expiring patents are expected to contribute billions of dollars towards the loss of revenue of drug manufacturers in the years to come. To save itself from
Expiring patents are expected to contribute billions of dollars towards the loss of revenue of drug manufacturers in the years to come. To save itself from
The re-posting of this analysis is part of a cross-posting collaboration with MediaLaws: Law and Policy of the Media in a Comparative Perspective. The explosion
Featured here is a summary of Pascale Chapdelaine’s paper recently published in the Buffalo Intellectual Property Law Journal and now available here. Whether copyright is
In the words of Taylor Swift, Joss Whedon is probably singing: “Are we out of the woods yet?” On April 13th, author Peter Gallagher (no,
The U.S. Copyright Office is currently in the process of conducting its 6th triennial rulemaking review under 17 U.S.C. § 1201 of the Digital Millennium
IP Osgoode is pleased to announce the release of a new book entitled “What’s Wrong with Copying?” by Prof. Abraham Drassinower. Reprinted below is the